An Algorithm for Prognosis of Upper Limb Paresis in Patients With Subacute Stroke
NCT ID: NCT03632499
Last Updated: 2021-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
103 participants
OBSERVATIONAL
2018-06-15
2020-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim study 2: Prediction of real life UL use. Method: A prospective cohort study. Main outcome measure study 1: Action Research Arm Test (ARAT), measuring UL motor function.
Main outcome study 2: use ratio between affected and unaffected UL measured by accellerometer.
Secondary outcome measure: Fugl-Meyer Motor Assessment for UL (FM).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Implementation of PREP2 Algorithm Into Clinical Practice
NCT04637984
Recovery of Upper Limb Paresis at Discharge After Stroke and Its Level of Use in Activities of Daily Living 3 to 6 Months Later (Post AVC-AVQ)
NCT03118648
Acute Effect of Mirror Therapy on Rehabilitation of Paretic Upper Extremity After Chronic Stroke
NCT03371290
Very Early Rehabilitation in Acute Ischemic Stroke
NCT01694992
Automatic Versus Intentional Movement Exercises to Enhance Arm Functions After Stroke
NCT01565044
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study 1 Aim: Assess the accuracy of PREP2 when applied in a subacute rehabilitation setting.
Hypothesis: PREP2 applied at day 14 post stroke accurately predicts UL function 3 months after stroke for a minimum of 75 % of the patients.
Method: A prospective cohort study. Setting and population: The study will take place at Hammel Neurorehabilitation Centre and University Research Clinic. Ninety patients will be included.
Inclusion criteria: First or recurrent ischemic or hemorrhagic stroke (diagnosis verified by CT or MR scan); New upper limp impairment; Less than 15 days post stroke; ≥ 18 years; Able to follow simple commands and cooperate with examinations Main outcome measure: Action Research Arm Test (ARAT), measuring UL motor function.
Secondary outcome measure: Fugl-Meyer Motor and sensory Assessment for UL. Functional Independence Measure (FIM).
Examined at baseline: Pain wil be assessed with a verbal rating scale. Inferior subluxation in the glenohumoral joint. Neglect will be assessed with star cancellation test and line bisection test
Study 2 Prediction of real life UL use Hypothesis: PREP2 can be used to predict real life UL use 3 months post stroke. Patients: The entire cohort from study 1 will be included. Real life use will be assessed with accelerometers at 3 months follow up.
Main outcome: is the use ratio between affected and unaffected UL.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rehabilitation
rehabilitation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* New upper limp impairment; Less than 15 days post stroke
* ≥ 18 years
* Able to follow simple commands and cooperate with examinations
Exclusion Criteria
* UL motor residuals from former stroke
* Severe illness with life expectancy \< 6 months
* Place of residence more than 1½ hours drive away and not reachable for follow up assessments
* Patients with contraindications for TMS are excluded from the TMS part of the study.
18 Years
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Camilla Lundquist
Hammel, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
63518
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.